Fragmented data does more than slow trials down. In some cases, it can limit eligible patients from participating in a trial ...

By the time someone reached me, they had often been on a diagnostic journey for years – misdiagnosed, undertreated, cycling ...

Sanofi will not be fined for disparaging an influenza vaccine sold by rival CSL in a marketing campaign that ran in the EU, ...

GSK is preparing to cut more than 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched ...

The Federal Trade Commission (FTC) and several US states have accused Martin Shkreli of violating a lifetime restraining ...

Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...

Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, has filed an IPO to raise additional ...

Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ...

From patient engagement apps to clinical trial management platforms, development teams are increasingly turning to AI coding ...

Saunders' latest spell as CEO started in 2023, as Bausch Health worked to spin Bausch + Lomb out as an independent public ...

Women and girls with autoimmune diseases are much more likely to have their condition misdiagnosed as psychiatric or ...

AstraZeneca has already filed for approval of its therapy for ultra-rare disease hypophosphatasia (HPP), after missing the ...